NEWS

News

Polifarma Has Been Accepted into the TURQUALITY Support Program!
Polifarma Has Been Accepted into the TURQUALITY Support Program!
Polifarma has been accepted into the TURQUALITY Support Program, led by the Ministry of Trade of the Republic of Türkiye—marking a highly...
Read more
Our Collaboration with TÜSEB on Clinical Trials for the Domestic Drug Active Ingredient and Drug Production Project for SMA Disease Received Extensive Media Coverage
Our Collaboration with TÜSEB on Clinical Trials for the Domestic Drug Active Ingredient and Drug Production Project for SMA Disease Received Extensive Media Coverage
Under the auspices of the Presidency of the Republic of Turkey, the 11th Turkish Medical World Congress was held in Ankara from...
Read more
A ‘Clinical Research Cooperation Protocol for the Domestic Production of Drugs and Active Pharmaceutical Ingredients for SMA’ was Signed Between Polifarma and Health Institutes of Türkiye (TÜSEB)
A ‘Clinical Research Cooperation Protocol for the Domestic Production of Drugs and Active Pharmaceutical Ingredients for SMA’ was Signed Between Polifarma and Health Institutes of Türkiye (TÜSEB)
The protocol, which carries strategic importance for Türkiye’s goals of localization in pharmaceuticals and achieving independence in the...
Read more
Polifarma Wins Three Awards at the OSB Stars Research!
Polifarma Wins Three Awards at the OSB Stars Research!
At the 2025 OSB Stars Research awards ceremony, held by OSBÜK (Organized Industrial Zones Supreme Council) with the honorary presence of our...
Read more
Our Information Technologies Director, Suat Özdemir, Has Been Recognized Among the “Technology Leaders Driving Digital Transformation”
Our Information Technologies Director, Suat Özdemir, Has Been Recognized Among the “Technology Leaders Driving Digital Transformation”
We are proud to announce that our Information Technologies Director, Suat Özdemir, has been featured on Fortune Türkiye’s “CTO List 2025”...
Read more
We Are Among “Türkiye’s Top 100 Women-Friendly Companies” and “Top 100 Women Executive-Friendly Companies”!
We Are Among “Türkiye’s Top 100 Women-Friendly Companies” and “Top 100 Women Executive-Friendly Companies”!
We are proud to be recognized by Capital Magazine among “Türkiye’s Top 100 Women-Friendly Companies” and “Top 100 Women Executive-Friendly...
Read more
We were at WHX Cape Town 2025!
We were at WHX Cape Town 2025!
We would like to thank all our esteemed visitors who visited our booth at the WHX Cape Town Fair, held at the Cape Town International Conven...
Read more
Polifarma: The Rising Star of R&D!
Polifarma: The Rising Star of R&D!
We have proudly climbed 57 places compared to last year in Turkishtime’s “Top 500 Companies by R&D Expenditures 2024” and now rank 76th amon...
Read more
Loading...

News

Polifarma Has Been Accepted into the TURQUALITY Support Program!
Polifarma Has Been Accepted into the TURQUALITY Support Program!
Polifarma has been accepted into the TURQUALITY Support Program, led by the Ministry of Trade of the Republic of Türkiye—marking a highly...
Read more
Our Collaboration with TÜSEB on Clinical Trials for the Domestic Drug Active Ingredient and Drug Production Project for SMA Disease Received Extensive Media Coverage
Our Collaboration with TÜSEB on Clinical Trials for the Domestic Drug Active Ingredient and Drug Production Project for SMA Disease Received Extensive Media Coverage
Under the auspices of the Presidency of the Republic of Turkey, the 11th Turkish Medical World Congress was held in Ankara from...
Read more
A ‘Clinical Research Cooperation Protocol for the Domestic Production of Drugs and Active Pharmaceutical Ingredients for SMA’ was Signed Between Polifarma and Health Institutes of Türkiye (TÜSEB)
A ‘Clinical Research Cooperation Protocol for the Domestic Production of Drugs and Active Pharmaceutical Ingredients for SMA’ was Signed Between Polifarma and Health Institutes of Türkiye (TÜSEB)
The protocol, which carries strategic importance for Türkiye’s goals of localization in pharmaceuticals and achieving independence in the...
Read more
Polifarma Wins Three Awards at the OSB Stars Research!
Polifarma Wins Three Awards at the OSB Stars Research!
At the 2025 OSB Stars Research awards ceremony, held by OSBÜK (Organized Industrial Zones Supreme Council) with the honorary presence of our...
Read more
Our Information Technologies Director, Suat Özdemir, Has Been Recognized Among the “Technology Leaders Driving Digital Transformation”
Our Information Technologies Director, Suat Özdemir, Has Been Recognized Among the “Technology Leaders Driving Digital Transformation”
We are proud to announce that our Information Technologies Director, Suat Özdemir, has been featured on Fortune Türkiye’s “CTO List 2025”...
Read more
We Are Among “Türkiye’s Top 100 Women-Friendly Companies” and “Top 100 Women Executive-Friendly Companies”!
We Are Among “Türkiye’s Top 100 Women-Friendly Companies” and “Top 100 Women Executive-Friendly Companies”!
We are proud to be recognized by Capital Magazine among “Türkiye’s Top 100 Women-Friendly Companies” and “Top 100 Women Executive-Friendly...
Read more
We were at WHX Cape Town 2025!
We were at WHX Cape Town 2025!
We would like to thank all our esteemed visitors who visited our booth at the WHX Cape Town Fair, held at the Cape Town International Conven...
Read more
Polifarma: The Rising Star of R&D!
Polifarma: The Rising Star of R&D!
We have proudly climbed 57 places compared to last year in Turkishtime’s “Top 500 Companies by R&D Expenditures 2024” and now rank 76th amon...
Read more
Loading...
P-ICON